title: Cinacalcet should be used to treat secondary hyperparathyroidism in stage 3-4 chronic kidney disease.
authors.affiliation: Graduate School of Medicine at University of Cantabria and Nephrology Department, Marqués de Valdecilla University Hospital, Santander, Spain. martinal@unican.es
authors.forename: Angel L M
authors.initials: AL
authors.lastname: de Francisco
authors.forename: Celestino
authors.initials: C
authors.lastname: Piñera
authors.forename: Rosa
authors.initials: R
authors.lastname: Palomar
mesh_terms: D000818:Animals; D000069449:Cinacalcet; D006801:Humans; D006962:Hyperparathyroidism, Secondary / Q000188:drug therapy* / Q000209:etiology; D007676:Kidney Failure, Chronic / Q000150:complications* / Q000175:diagnosis; D009281:Naphthalenes / Q000627:therapeutic use*; D012720:Severity of Illness Index; D016896:Treatment Outcome
chemical_list: D009281:Naphthalenes; D000069449:Cinacalcet